Bando Chemical Industries, Ltd. (5195.T)
JPY 1842.0
(0.71%)
JPY 1842.0
(0.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 108.27 Billion | 103.6 Billion | 93.74 Billion | 81.37 Billion | 90.24 Billion | 90.79 Billion |
| Cost of Revenue | 77.24 Billion | 74.18 Billion | 66.08 Billion | 56.52 Billion | 63.18 Billion | 63.27 Billion |
| Gross Profit | 31.03 Billion | 29.42 Billion | 27.66 Billion | 24.85 Billion | 27.06 Billion | 27.52 Billion |
| Operating Expenses | 23.26 Billion | 22.61 Billion | 26.02 Billion | 19.99 Billion | 25.69 Billion | 21.12 Billion |
| Selling, General and Administrative Expenses | 23.44 Billion | 22.68 Billion | 21.78 Billion | 19.91 Billion | 21.81 Billion | 20.83 Billion |
| Research and Development Expenses | 4.19 Billion | 4.11 Billion | 4.02 Billion | 4.09 Billion | 4.42 Billion | 4.45 Billion |
| Other Expenses | -4.19 Billion | - | 4.23 Billion | 83 Million | 3.87 Billion | 283 Million |
| Cost and Expenses | 100.69 Billion | 96.79 Billion | 92.1 Billion | 76.51 Billion | 88.87 Billion | 84.39 Billion |
| Operating Income | 7.58 Billion | 8.25 Billion | 2.66 Billion | 5.37 Billion | 2.05 Billion | 7.15 Billion |
| Interest Expense | 363 Million | 373 Million | 130 Million | 144 Million | 368 Million | 532 Million |
| Income Tax Expense | 2.45 Billion | 2.78 Billion | 2.19 Billion | 1.66 Billion | 1.39 Billion | 1.76 Billion |
| Earnings before Tax | 7.2 Billion | 8.54 Billion | 3.41 Billion | 5.61 Billion | 2.09 Billion | 6.89 Billion |
| Net Income | 6.18 Billion | 5.72 Billion | 1.21 Billion | 3.94 Billion | 682 Million | 5.1 Billion |
| Earnings Per Share Basic | 142.55 | 129.96 | 26.91 | 86.56 | 14.91 | 111.30 |
| Earnings Per Share Diluted | 142.55 | 129.96 | 26.91 | 86.56 | 14.91 | 111.30 |
| Weighted Average Shares Outstanding | 43.35 Million | 44.02 Million | 44.99 Million | 45.55 Million | 45.73 Million | 45.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.35 Million | 44.02 Million | 44.99 Million | 45.55 Million | 45.73 Million | 45.82 Million |
| Gross Margin | 0.29 | 0.28 | 0.30 | 0.31 | 0.30 | 0.30 |
| EBIT Margin | 0.13 | 0.14 | 0.10 | 0.14 | 0.09 | 0.13 |
| Profit Margin | 0.06 | 0.06 | 0.01 | 0.05 | 0.01 | 0.06 |
| EBITDA | 13.55 Billion | 12.75 Billion | 11.88 Billion | 10.98 Billion | 10.77 Billion | 10.81 Billion |
| Earnings Before Tax Margin | 0.07 | 0.08 | 0.03 | 0.07 | 0.02 | 0.08 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 29.34 Billion | 27.57 Billion | 108.27 Billion | 26.77 Billion | 27.37 Billion | 26.55 Billion |
| Cost of Revenue | 21.1 Billion | 19.74 Billion | 77.24 Billion | 18.9 Billion | 19.53 Billion | 19.06 Billion |
| Gross Profit | 8.24 Billion | 7.83 Billion | 31.03 Billion | 7.87 Billion | 7.84 Billion | 7.48 Billion |
| Operating Expenses | 6.28 Billion | 6.14 Billion | 23.44 Billion | 5.67 Billion | 5.75 Billion | 5.69 Billion |
| Selling, General and Administrative Expenses | 6.28 Billion | 6.14 Billion | - | 5.73 Billion | 5.83 Billion | 5.73 Billion |
| Research and Development Expenses | - | 4.19 Billion | - | 13.52 Billion | 971 Million | 1.04 Billion |
| Other Expenses | 1 Million | - | - | - | - | - |
| Cost and Expenses | 27.38 Billion | 25.88 Billion | 100.69 Billion | 24.58 Billion | 25.28 Billion | 24.75 Billion |
| Operating Income | 1.96 Billion | 1.69 Billion | 7.58 Billion | 2.39 Billion | 2.5 Billion | 2.01 Billion |
| Interest Expense | 62 Million | 141 Million | 363 Million | 386 Million | 89 Million | 51 Million |
| Income Tax Expense | 910 Million | 53 Million | 2.45 Billion | 682 Million | 891 Million | 831 Million |
| Earnings before Tax | 2.85 Billion | 627 Million | 7.2 Billion | 2.01 Billion | 2.69 Billion | 2.71 Billion |
| Net Income | 1.93 Billion | 1.18 Billion | 6.18 Billion | 1.32 Billion | 1.78 Billion | 1.88 Billion |
| Earnings Per Share Basic | 45.09 | 27.68 | - | 30.44 | 41.10 | 43.26 |
| Earnings Per Share Diluted | 45.09 | 27.68 | - | 30.44 | 41.10 | 43.26 |
| Weighted Average Shares Outstanding | 42.84 Million | 43.03 Million | 43.35 Million | 43.4 Million | 43.5 Million | 43.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.84 Million | 43.03 Million | 43.35 Million | 43.4 Million | 43.5 Million | 43.5 Million |
| Gross Margin | 0.28 | 0.28 | 0.29 | 0.29 | 0.29 | 0.28 |
| EBIT Margin | 0.12 | 0.11 | - | 0.14 | 0.16 | 0.16 |
| Profit Margin | 0.07 | 0.04 | 0.06 | 0.05 | 0.07 | 0.07 |
| EBITDA | 3.43 Billion | 3.16 Billion | - | 3.87 Billion | 4.24 Billion | 4.2 Billion |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.07 | 0.09 | 0.09 | 0.08 |
RGRNF
CONCORDBIO
RAMCOSYS
RNMBF
SGHIF
PDRDF